Its an investigational compound
All the mice treated with the therapeutic groups, except for Pd1-Pd2-SA@Gel, died within 21 days due to the aggressive and drug-resistant characteristics of DR-B16F10 melanoma
J Pharm Exp Therap 244(3):1036-1039
The principal aims were to optimize the operating conditions, to optimize the specific signal for ESAs while decreasing the cross-reactivity to other proteins, to demonstrate that this method could detect all types of ESAs, to determine if the method could be used with urine and blood samples, to compare this new method to the actual accredited methods and finally to put in place and validate a testing procedure that could be transferred to other anti-doping laboratories
During the review, the committee will likely consider: The extensive body of published research on GHK-Cu (decades of studies) Safety data for both injectable and topical routes The clinical rationale for copper peptide therapy in anti-aging and wound healing Quality control considerations for compounding GHK-Cu formulations Public comments from patients, dermatologists, anti-aging practitioners, and pharmacies Given GHK-Cu's long history of use and substantial research base, many in the peptide therapy community are cautiously optimistic about a positive PCAC recommendation particularly for the topical route
Aim for about 2 to 2.5 liters of fluids daily, more during hot flashes
